Henderson Group »

Intra Cellular Therapies shares owned by Henderson Group

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Henderson Group from 13F filings

Historical chart of Henderson Group investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Henderson Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Henderson Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.8M 40k 68.49
2024-03-31 $28M 401k 69.20
2023-12-31 $35M 489k 71.62
2023-09-30 $25M 480k 52.09
2023-06-30 $39M 611k 63.32
2023-03-31 $42M 775k 54.14
2022-12-31 $15M 287k 52.91
2022-09-30 $11M 227k 46.48
2022-03-31 $7.8M 127k 61.19
2021-12-31 $7.7M 148k 52.28
2021-09-30 $5.4M 146k 37.25
2021-06-30 $5.4M 132k 40.81
2021-03-31 $4.0M 117k 33.99
2020-12-31 $1.5M 47k 31.83
2017-09-30 $552k 35k 15.77
2017-06-30 $435k 35k 12.43